FASLG and autoimmune polyendocrinopathy: Direct proof that endothelial dysfunction in APS patients is based on impairment of nitric oxide (NO) production is that plasma antiphospholipid antibody (aPL) levels are inversely correlated with urinary NO metabolite excretion, and APS patients have lower levels of plasma nitrites compared to control subjects [3,4].